Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2vcg | S17 | Histone deacetylase-like amidohydrolase | 3.5.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2vcg | S17 | Histone deacetylase-like amidohydrolase | 3.5.1 | 1.000 | |
2gh6 | CF3 | Histone deacetylase-like amidohydrolase | 3.5.1 | 0.604 | |
1zz1 | SHH | Histone deacetylase-like amidohydrolase | 3.5.1 | 0.557 | |
1s3u | TQD | Dihydrofolate reductase | 1.5.1.3 | 0.498 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.489 | |
1drf | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.482 | |
4eil | FOL | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.481 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.479 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.479 | |
3qfx | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.477 | |
3aiq | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase 1b, chloroplastic | 3.2.1.182 | 0.476 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.472 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.471 | |
1k9s | FM2 | Purine nucleoside phosphorylase DeoD-type | / | 0.470 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.470 | |
3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.469 | |
4zas | TYD | CalS13 | / | 0.468 | |
2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.467 | |
3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.466 | |
3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
3vjc | ZGA | Squalene synthase | 2.5.1.21 | 0.466 | |
3l6j | Z90 | Alr2278 protein | / | 0.465 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.464 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.463 | |
4dbu | BT9 | Aldo-keto reductase family 1 member C3 | / | 0.463 | |
5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.463 | |
1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.462 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
4bfp | SWY | Tankyrase-2 | 2.4.2.30 | 0.461 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.461 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.461 | |
1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.460 | |
2o7p | NAP | Riboflavin biosynthesis protein RibD | / | 0.459 | |
3fu8 | 3DM | Laccase-1 | 1.10.3.2 | 0.459 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.459 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.458 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
4iae | 1DX | Alr2278 protein | / | 0.458 | |
2bxo | OPB | Serum albumin | / | 0.457 | |
2z7g | EH9 | Adenosine deaminase | 3.5.4.4 | 0.457 | |
4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.457 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.455 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.454 | |
4jqh | 1MF | Alr2278 protein | / | 0.453 | |
4yx6 | FMN | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.453 | |
5bp9 | SAH | Putative methyltransferase protein | / | 0.453 | |
3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.452 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.452 | |
3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
4myq | 19T | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.451 | |
4rw4 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
5ab6 | CAA | Nonspecific lipid-transfer protein, putative | / | 0.451 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
4dsb | A8S | Abscisic acid receptor PYL3 | / | 0.450 | |
2ze2 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.449 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.449 | |
1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
3jsu | KA5 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.448 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
2hq9 | FAD | Mll6688 protein | / | 0.446 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
3a1l | 2CC | Cytochrome P450 | / | 0.446 | |
3o4r | NAP | Dehydrogenase/reductase SDR family member 4 | 1.1.1.184 | 0.446 | |
3up3 | XCA | aceDAF-12 | / | 0.446 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.446 | |
1e1f | PSG | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase 1, chloroplastic | 3.2.1.182 | 0.445 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.445 | |
1sqq | OST | Cytochrome b | / | 0.445 | |
3n0h | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
4da7 | AC2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.445 | |
4dm6 | TTB | Retinoic acid receptor beta | / | 0.445 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.445 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
2p15 | EZT | Estrogen receptor | / | 0.444 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
4ea2 | RWZ | Dehydrosqualene synthase | / | 0.444 | |
3w0h | W12 | Vitamin D3 receptor | / | 0.443 | |
3zec | ANP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.443 | |
4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.442 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.442 | |
4h38 | 0YX | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.442 | |
2dhf | DZF | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3o8g | O8G | HTH-type transcriptional regulator EthR | / | 0.441 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.441 | |
1zdw | FLV | Prenyltransferase | / | 0.440 | |
2b5j | 3AC | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.440 | |
3fu9 | KIB | Laccase-1 | 1.10.3.2 | 0.440 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.440 |